Maria Angela D'AMico

Maria Angela D'AMico

Auto-generated profile, based on publicly available information

Maria Angela D'AMico

Department of Medicine and Aging Sciences, University G. dAnnunzio, Chieti-Pescara, Italy

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2014 in Endocrine Connections
Verified
Journal Article
Open access
PDF file
MDMaria Angela D'AMico
Maria Angela D'AMico
BGBarbara Ghinassi
Barbara Ghinassi
PASCAL IZZICUPOPASCAL IZZICUPO
PASCAL IZZICUPO
Lamberto ManzoliLamberto Manzoli
Lamberto Manzoli
ABAngela Di Baldassarre
Angela Di Baldassarre
Chromogranin A (CgA (CHGA)) is the major soluble protein co-stored and co-released with catecholamines and can function as a pro-hormone by giving rise to several bioactive peptides. This review summarizes the physiological functions, the pathogenic implications, and the recent use of these molecules as biomarkers in several pathological conditions. A thorough literature review of the electronic healthcare databases MEDLINE, from January 1985 to September 2013, was conducted to identify articles and studies concerned with CgA and its processing. The search strategies utilized keywords such as chromogranin A, vasostatins 1 and 2, chromofungin, chromacin, pancreastatin, catestatin, WE14, chromostatin, GE25, parastatin, and serpinin and was supplemented by the screening of references from included papers and review articles. A total of 209 English-language, peer-reviewed original articles or reviews were examined. The analysis of the retrospective literature suggested that CgA and its several bioactive fragments exert a broad spectrum of regulatory activities by influencing the endocrine, the cardiovascular, and the immune systems and by affecting the glucose or calcium homeostasis. As some peptides exert similar effects, but others elicit opposite responses, the regulation of the CgA processing is critical to maintain homeostasis, whereas an unbalanced production of peptides that exert opposing effects can have a pathogenic role in several diseases. These clinical implications entail that CgA and its derived peptides are now used as diagnostic and prognostic markers or to monitor the response to pharmacological intervention not only in endocrine tumors, but also in cardiovascular, inflammatory, and neuropsychiatric diseases.

1 January 2005 in Neuroscience
Verified
Journal Article
Closed access
ACAnnamaria Cimini
Annamaria Cimini
EBE. Benedetti
E. Benedetti
LCL. Cristiano
L. Cristiano
PSP. Sebastiani
P. Sebastiani
MDM.A. D'Amico
M.A. D'Amico
SLS. Di Loreto
S. Di Loreto

27 March 2007 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
SLS. Di Loreto
S. Di Loreto
BDB. D'Angelo
B. D'Angelo
MDM.A. D'Amico
M.A. D'Amico
EBE. Benedetti
E. Benedetti
LCL. Cristiano
L. Cristiano
ACAnnamaria Cimini
Annamaria Cimini

9 November 2011 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
SGSabina Gallina
Sabina Gallina
Michele Di MauroMichele Di Mauro
Michele Di Mauro
MDMaria Angela D’amico
Maria Angela D’amico
EDEmanuele D’angelo
Emanuele D’angelo
ASAndrea Sablone
Andrea Sablone
ABAngela Di Baldassarre
Angela Di Baldassarre

1 July 2012 in Psychology of Sport and Exercise
Verified
Journal Article
Closed access
CRClaudio Robazza
Claudio Robazza
SGSabina Gallina
Sabina Gallina
MDMaria Angela D'AMico
Maria Angela D'AMico
PASCAL IZZICUPOPASCAL IZZICUPO
PASCAL IZZICUPO
ABAdriana Bascelli
Adriana Bascelli
ABAngela Di Baldassarre
Angela Di Baldassarre

1 December 2014 in Cell Transplantation
Verified
Journal Article
Closed access
IAIvana Antonucci
Ivana Antonucci
RPRoberta Di Pietro
Roberta Di Pietro
MAMelissa Alfonsi
Melissa Alfonsi
MCMaria Antonietta Centurione
Maria Antonietta Centurione
LCLucia Centurione
Lucia Centurione
LSLiborio Stuppia
Liborio Stuppia
Human amniotic fluid-derived stem cells (AFSCs) represent a novel class of broadly multipotent stem cells sharing characteristics of both embryonic and adult stem cells. However, both the origin of these cells and their actual properties in terms of pluripotent differentiation potential are still debated. In order to verify the presence of features of pluripotency in human second trimester AFSCs, we have investigated the ability of these cells to form in vitro three-dimensional aggregates, known as embryoid bodies (EBs), and to express specific genes of embryonic stem cells (ESCs) and primordial germ cells (PGCs). EBs were obtained after 5 days of AFSC culture in suspension and showed positivity for alkaline phosphatase (AP) staining and for specific markers of pluripotency (OCT4 and SOX2). Moreover, EB-derived cells showed the expression of specific transcripts of the three germ layers. RT-PCR analysis, carried out at different culture times (second, third, fourth, fifth, and eighth passages), revealed the presence of specific markers of ESCs (such as FGF4 and DAPPA4), as well as of markers typical of PGCs and, in particular, genes involved in early stages of germ cell development (Fragilis, Stella, Vasa, c-Kit, Rnf17). Finally, the expression of genes related to the control of DNA methylation (DNMT3A, DNMT3b1, DNMT1, DNMT3L, MBD1, MBD2, MBD3, MDB4, MeCP2), as well as the lack of inactivation of the X-chromosome in female samples, was also demonstrated. Taken together, these data provide further evidence for the presence of common features among human AFSCs, PGCs, and ESCs.